Showing results (71-80 of 91) with videos related to
Sort By:
Pageof 10
Research Square|November 24, 2025
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLTheodoros Karantanos, Nour Naji, Taha Ahmedna, et al.Journal of Cellular and Molecular Medicine|September 5, 2020
Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosisPatric Teodorescu, Sergiu Pasca, Ancuta Jurj, et al.Journal of Cellular and Molecular Medicine|September 5, 2023
Design and preclinical testing of an anti-CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemiaAdrian Bogdan Tigu, Catalin Sorin Constantinescu, Patric Teodorescu, et al.Leukemia|February 21, 2020
Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative StudySabine Kayser, Ramy Rahmé, David Martínez-Cuadrón, et al.Science Translational Medicine|March 2, 2021
TCR β chain-directed bispecific antibodies for the treatment of T cell cancersSuman Paul, Alexander H Pearlman, Jacqueline Douglass, et al.Cell Death and Differentiation|March 28, 2024
AMPK inhibition sensitizes acute leukemia cells to BH3 mimetic-induced cell deathJia Jia, Wenbo Ji, Antoine N Saliba, et al.Biorxiv : the Preprint Server for Biology|September 2, 2025
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLNour Sabiha Naji, Taha Ahmedna, J David Peske, et al.Leukemia|January 5, 2020
Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDSJoshua F Zeidner, Hanna A Knaus, Amer M Zeidan, et al.Ejhaem|March 11, 2021
Increased body mass index is a risk factor for acute promyelocytic leukemiaSarah M Kashanian, Andrew Y Li, Moaath Mustafa Ali, et al.Cancer Research|January 8, 2021
CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute LeukemiaHusheng Ding, Nicole D Vincelette, Cordelia D McGehee, et al.Pageof 10